---
title: "Aspire Pharma Holdings Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e168e121-d326-4be3-beb4-ca01d3f7b9f2
json: https://whiteintel.dev/api/public/dossier/e168e121-d326-4be3-beb4-ca01d3f7b9f2
identifier: psc:J2bKDj5jwuLkp2UVcxQuNJ17R40
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Aspire Pharma Holdings Limited

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `psc:J2bKDj5jwuLkp2UVcxQuNJ17R40`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e168e121-d326-4be3-beb4-ca01d3f7b9f2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e168e121-d326-4be3-beb4-ca01d3f7b9f2  

## Ownership & control

### Holdings / subsidiaries

- **ASPIRE PHARMA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/4ad8b6a7-dd96-5690-8d34-a94532271319

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Aspire Pharma Holdings Limited**. Human view: https://whiteintel.dev/entity/e168e121-d326-4be3-beb4-ca01d3f7b9f2 · Structured JSON: https://whiteintel.dev/api/public/dossier/e168e121-d326-4be3-beb4-ca01d3f7b9f2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._